Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure.

Aronson D, Burger AJ.

J Card Fail. 2010 Jul;16(7):541-7. doi: 10.1016/j.cardfail.2010.02.001. Epub 2010 Mar 19.

PMID:
20610229
2.

Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.

Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP.

Circulation. 2010 Jul 20;122(3):265-72. doi: 10.1161/CIRCULATIONAHA.109.933275. Epub 2010 Jul 6.

3.

Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.

Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O'Connor CM.

Am J Cardiol. 2010 Jun 15;105(12):1794-7. doi: 10.1016/j.amjcard.2010.01.355. Epub 2010 Apr 27.

4.

Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study.

Metra M, Cleland JG, Weatherley BD, Dittrich HC, Givertz MM, Massie BM, O'Connor CM, Ponikowski P, Teerlink JR, Voors AA, Cotter G.

Eur J Heart Fail. 2010 May;12(5):499-507. doi: 10.1093/eurjhf/hfq021. Epub 2010 Mar 12.

5.

Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.

Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB.

J Card Fail. 2010 Mar;16(3):188-93. doi: 10.1016/j.cardfail.2009.11.005. Epub 2010 Jan 6.

PMID:
20206891
6.

Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?

Felker GM, O'Connor CM, Braunwald E; Heart Failure Clinical Research Network Investigators.

Circ Heart Fail. 2009 Jan;2(1):56-62. doi: 10.1161/CIRCHEARTFAILURE.108.821785. Review. No abstract available.

7.

Effects of tolvaptan on dyspnoea relief from the EVEREST trials.

Pang PS, Konstam MA, Krasa HB, Swedberg K, Zannad F, Blair JE, Zimmer C, Teerlink JR, Maggioni AP, Burnett JC Jr, Grinfeld L, Ouyang J, Udelson JE, Gheorghiade M; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Investigators.

Eur Heart J. 2009 Sep;30(18):2233-40. doi: 10.1093/eurheartj/ehp253. Epub 2009 Jun 27.

8.

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW.

Circulation. 2009 Apr 14;119(14):1977-2016. doi: 10.1161/CIRCULATIONAHA.109.192064. Epub 2009 Mar 26. No abstract available.

9.

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2009 Jan 27;119(3):e21-181. doi: 10.1161/CIRCULATIONAHA.108.191261. Epub 2008 Dec 15. No abstract available. Erratum in: Circulation. 2011 Oct 18;124(16):e424. Circulation. 2010 Jul 6;122(1):e11. Circulation. 2009 Jan 27;119(3):e182.

10.

Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity in acute heart failure (MEASURE-AHF).

Allen LA, Metra M, Milo-Cotter O, Filippatos G, Reisin LH, Bensimhon DR, Gronda EG, Colombo P, Felker GM, Cas LD, Kremastinos DT, O'Connor CM, Cotter G, Davison BA, Dittrich HC, Velazquez EJ.

J Card Fail. 2008 Nov;14(9):777-84. doi: 10.1016/j.cardfail.2008.07.188. Epub 2008 Aug 15.

11.

Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.

Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O'Connor CM, Califf RM, Adams KF Jr.

Eur J Heart Fail. 2007 Oct;9(10):1064-9. Epub 2007 Aug 24.

12.

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA; UNLOAD Trial Investigators.

J Am Coll Cardiol. 2007 Feb 13;49(6):675-83. Epub 2007 Jan 26. Erratum in: J Am Coll Cardiol. 2007 Mar 13;49(10):1136.

13.

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.

Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW; ESCAPE Investigators and ESCAPE Study Coordinators.

JAMA. 2005 Oct 5;294(13):1625-33.

PMID:
16204662
14.

Continuous infusion versus bolus injection of loop diuretics in congestive heart failure.

Salvador DR, Rey NR, Ramos GC, Punzalan FE.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003178. Review.

PMID:
16034890
15.

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.

Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, O'Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM.

Am Heart J. 2004 Feb;147(2):331-8.

PMID:
14760333
16.
17.

Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction.

Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ.

Circulation. 1999 Sep 21;100(12):1311-5.

18.

Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.

Dormans TP, van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P.

J Am Coll Cardiol. 1996 Aug;28(2):376-82.

19.

Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance.

van Meyel JJ, Smits P, Dormans T, Gerlag PG, Russel FG, Gribnau FW.

J Intern Med. 1994 Apr;235(4):329-34.

PMID:
8151264
20.

Diuresis with continuous infusion of furosemide after cardiac surgery.

Copeland JG, Campbell DW, Plachetka JR, Salomon NW, Larson DF.

Am J Surg. 1983 Dec;146(6):796-9.

PMID:
6650766

Supplemental Content

Support Center